A multicenter, randomized, double-blind, placebo-controlled phase III study of monosialoganglioside (GM1) preventing neurotoxicity induced by cisplatin-based chemotherapy in non-small cell lung cancer patients.

Reply to “Letter to the Editor on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by V. C. G. Tjan-Heijnen, P. E. Postmus &A. Ardizzoni(Ann Oncol 2002; 13: 485–486)

Annals of Oncology ◽

10.1093/annonc/mdf139 ◽

2002 ◽

Vol 13 (3) ◽

pp. 486 ◽

Cited By ~ 1

Author(s):

P. Bunn

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Annals of Oncology ◽

10.1023/a:1012545507920 ◽

2001 ◽

Vol 12 (10) ◽

pp. 1359-1368 ◽

Cited By ~ 80

Author(s):

V.C.G. Tjan-Heijnen ◽

P.E. Postmus ◽

A. Ardizzoni ◽

Ch. Manegold ◽

J. Burghouts ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)

Annals of Oncology ◽

10.1093/annonc/mdg073 ◽

2003 ◽

Vol 14 (2) ◽

pp. 248-257 ◽

Cited By ~ 19

Author(s):

V.C.G. Tjan-Heijnen ◽

S. Caleo ◽

P.E. Postmus ◽

A. Ardizzoni ◽

J.T.M. Burghouts ◽

...

Keyword(s):

Lung Cancer ◽

Economic Evaluation ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Editorial comments on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study’

Annals of Oncology ◽

10.1023/a:1012579018035 ◽

2001 ◽

Vol 12 (10) ◽

pp. 1339-1340 ◽

Cited By ~ 5

Author(s):

P.A. Bunn

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Cited By ~ 14

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181da36db ◽

2010 ◽

Vol 5 (7) ◽

pp. 1042-1047 ◽

Cited By ~ 6

Author(s):

Nobuyuki Yamamoto ◽

Yutaka Nishiwaki ◽

Shunichi Negoro ◽

Haiyi Jiang ◽

Yohji Itoh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Control ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.01.022 ◽

2017 ◽

Vol 12 (5) ◽

pp. 843-849 ◽

Cited By ~ 12

Author(s):

Maria Q. Baggstrom ◽

Mark A. Socinski ◽

Xiaofei F. Wang ◽

Lin Gu ◽

Thomas E. Stinchcombe ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Combination Chemotherapy ◽

Small Cell ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Reply to the article “Editorial comment on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339–1340)

Annals of Oncology ◽

10.1093/annonc/mdf138 ◽

2002 ◽

Vol 13 (3) ◽

pp. 485-486 ◽

Cited By ~ 3

Author(s):

V.C.G. Tjan-Heijnen ◽

P.E. Postmus ◽

A. Ardizzoni

Keyword(s):

Lung Cancer ◽

Editorial Comment ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease

Annals of Oncology ◽

10.1093/annonc/mdq036 ◽

2010 ◽

Vol 21 (9) ◽

pp. 1810-1816 ◽

Cited By ~ 76

Author(s):

P. Zatloukal ◽

F. Cardenal ◽

A. Szczesna ◽

V. Gorbunova ◽

V. Moiseyenko ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Extensive Disease ◽

Lung Cancer Patients ◽